Ajanta Pharma Ltd
NSE:AJANTPHARM
During the last 3 months Ajanta Pharma Ltd insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 18% over this period (open performance analysis).
The last transaction was made on
Feb 16, 2024
by
Arvind K Agrawal
(Director - Corporate Strategy & Project Management)
, who
sold
32.3m INR
worth of AJANTPHARM shares.
During the last 3 months Ajanta Pharma Ltd insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 18% over this period (open performance analysis).
The last transaction was made on
Feb 16, 2024
by
Arvind K Agrawal
(Director - Corporate Strategy & Project Management)
, who
sold
32.3m INR
worth of AJANTPHARM shares.
Ajanta Pharma Ltd
Glance View
In the bustling landscape of the Indian pharmaceutical industry, Ajanta Pharma Ltd. has carved a niche for itself with a blend of strategic innovation and market smartness. Founded in 1973, the company swiftly harnessed the dynamics of a growing market by focusing on specialty therapeutic segments including cardiology, dermatology, ophthalmology, and pain management. With a distinctive approach that merges global aspirations with local market insights, Ajanta Pharma has established itself as a significant player not just in India, but also across over 30 countries. The company's success is driven by its sustained emphasis on research and development, which fuels its capabilities to roll out new, affordable formulations addressing unmet medical needs. Ajanta Pharma’s business model thrives on a two-pronged strategy: focusing on high-growth emerging markets and capitalizing on the constantly evolving healthcare demands in regulated markets like the United States. The company's adeptness at manufacturing efficiency and its vertically integrated operations enable it to maintain competitive cost structures, delivering value through robust margins. The revenue streams are further amplified by its prowess in developing generic drugs for the American market, where it navigates through complex regulatory landscapes to outpace competitors. Underpinned by a strong commitment to quality and patient-centric innovation, Ajanta Pharma’s operations exemplify a balanced growth trajectory, reinforcing its status as a dynamic and responsive healthcare entity.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
You don't have any saved screeners yet